Skip to main content

In the News

Image
U.S. Capitol Building at Twighlight
May 14, 2021

Republicans in Congress are introducing two new bills to combat what they call the “job-killing Biden agenda.”

Image
United States Capital East entrance
May 12, 2021

Congresswoman Diana Harshbarger (R-Tenn.) has introduced new legislation that would reform occupational licensing regulations.

With the support of the Republican Study Committee, Harshbarger introduced the Freedom to Work Act to encourage states and the federal government to roll back on these legislations.

Image
Art competition winner 2021
May 5, 2021

U.S. Rep. Diana Harshbarger has announced the First District’s winning entry in the 2021 Congressional Art Competition.

“I would like to congratulate Luke Pennington on winning Tennessee’s First District spot in the Congressional Art Competition,” Harshbarger said in a press release.

Image
Congresswoman Harshbarger on a gun boat at the border
April 22, 2021

I visited the Rio Grande Valley sector of our southern border near McAllen, Texas, along with colleagues from the House Homeland Security Committee to see the national security, humanitarian and public health border crisis for myself.

Image
Congresswoman Harshbarger and colleagues at the border wall
April 15, 2021

Tennessee Rep. Diana Harshbarger is back in D.C. after visiting the U.S.-Mexico border.

The Republican representing Tennessee’s First Congressional District met with Border Patrol agents on the crisis they are now dealing with as more migrants flee countries like Mexico, Guatemala and Honduras to find refuge the U.S.

Image
Rep. Diana Harshbarger Tennessee’s 1st Congressional District
March 15, 2021

Rep. Diana Harshbarger has introduced her first bill, legislation that she says could lead to lower prescription drug costs. To read the article, visit here

Issues:Health Care
Image
East Tennessee mountains
March 11, 2021

Rep. Diana Harshbarger voted against two Democratic efforts to expand background check requirements for firearms sales. Click here to read the full article.

Image
Tree-lined side of the Capitol building
February 12, 2021

WASHINGTON (WJHL) — Neopharma’s pharmaceutical manufacturing facility in Bristol will keep its critical infrastructure designation even after the COVID-19 pandemic is over.